Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Npj Drug Discovery
|
July 1, 2026
Drugging Ras trafficking-are there new roads to travel?
Elisabeth Schaffner-Reckinger, Atanasio Gómez-Mulas, Daniel Kwaku Abankwa
International Journal of Biological Macromolecules
|
November 27, 2024
The lack of trade-off between conformational stability and binding affinity in a nanobody with therapeutic potential for a misfolding disease
Atanasio Gómez-Mulas, Athi N Naganathan, Angel L Pey
FEBS Letters
|
November 27, 2024
Thermodynamic versus kinetic basis for the high conformational stability of nanobodies for therapeutic applications
Atanasio Gómez-Mulas, Mario Cano-Muñoz, Eduardo Salido Ruiz, et al.
Chembiochem : a European Journal of Chemical Biology
|
November 18, 2025
Development of a Genetically Encoded and Potent PDE6D Inhibitor
Atanasio Gómez-Mulas, Elisabeth Schaffner-Reckinger, Hanne Peeters, et al.
FEBS Letters
|
September 19, 2023
Structural dynamics at the active site of the cancer-associated flavoenzyme NQO1 probed by chemical modification with PMSF
Alice Grieco, Miguel A Ruiz-Fresneda, Atanasio Gómez-Mulas, et al.
FEBS Letters
|
January 20, 2024
Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants
Pavla Vankova, Juan Luis Pacheco-Garcia, Dmitry S Loginov, et al.
Cell Death & Disease
|
July 11, 2026
K-Ras controls asymmetric cell divisions from the primary cilium
Rohan Chippalkatti, Elisabeth Schaffner-Reckinger, Anthoula Gaigneaux, et al.
International Journal of Biological Macromolecules
|
January 1, 2026
Nanobodies as therapies for loss-of-function misfolding diseases: the example of Primary Hyperoxaluria Type 1
Mirco Dindo, Atanasio Gómez-Mulas, Juan Luis Pacheco-García, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Npj Drug Discovery
|
July 1, 2026
Drugging Ras trafficking-are there new roads to travel?
Elisabeth Schaffner-Reckinger, Atanasio Gómez-Mulas, Daniel Kwaku Abankwa
International Journal of Biological Macromolecules
|
November 27, 2024
The lack of trade-off between conformational stability and binding affinity in a nanobody with therapeutic potential for a misfolding disease
Atanasio Gómez-Mulas, Athi N Naganathan, Angel L Pey
FEBS Letters
|
November 27, 2024
Thermodynamic versus kinetic basis for the high conformational stability of nanobodies for therapeutic applications
Atanasio Gómez-Mulas, Mario Cano-Muñoz, Eduardo Salido Ruiz, et al.
Chembiochem : a European Journal of Chemical Biology
|
November 18, 2025
Development of a Genetically Encoded and Potent PDE6D Inhibitor
Atanasio Gómez-Mulas, Elisabeth Schaffner-Reckinger, Hanne Peeters, et al.
FEBS Letters
|
September 19, 2023
Structural dynamics at the active site of the cancer-associated flavoenzyme NQO1 probed by chemical modification with PMSF
Alice Grieco, Miguel A Ruiz-Fresneda, Atanasio Gómez-Mulas, et al.
FEBS Letters
|
January 20, 2024
Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants
Pavla Vankova, Juan Luis Pacheco-Garcia, Dmitry S Loginov, et al.
Cell Death & Disease
|
July 11, 2026
K-Ras controls asymmetric cell divisions from the primary cilium
Rohan Chippalkatti, Elisabeth Schaffner-Reckinger, Anthoula Gaigneaux, et al.
International Journal of Biological Macromolecules
|
January 1, 2026
Nanobodies as therapies for loss-of-function misfolding diseases: the example of Primary Hyperoxaluria Type 1
Mirco Dindo, Atanasio Gómez-Mulas, Juan Luis Pacheco-García, et al.
Page
of 1